ARWR vs MOS · rev $829.4M vs P/E 161, rev $5.82B
Arrowhead Pharmaceuticals Inc (ARWR) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported MOS revenue for 2026-06-30 was $5.82B. Net income was -$530.4M. Revenue was up 94.2% from 2026-03-31 to 2026-06-30. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
ARWR currently screens at market cap $10.59B. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the ARWR and MOS stock pages for the full models.
Not investment advice.